CRMD
CorMedixANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
9
U.S. public peers
Grade Position
Above peers
vs peer average
CRMD vs peer average
80/100
CRMD vs. peer average (A vs. C)
Grade spread
A 2 · B 2 · C 2 · D 1 · F 2
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
BBOT is the first available peer comparator.
A nearby market-cap biotech anchor, yet still much more clinical-stage and less directly comparable to CorMedix's current commercial revenue profile.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CRMD
CorMedix
BBOT
BridgeBio Oncology Therapeutics
Grade
A
F
Momentum
65
17
Value
68
51
Sentiment
100
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs BBOT
CRMD / BBOT
Grade Position
Above peers
CRMD vs. peer average (A vs. C)
80/100
Momentum
65
CRMDValue
68
CRMDSentiment
100
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CRMD
BBOT is the first peer returned for this comparison set.